Cumulus Oncology, Europe’s first oncology-focused biotech creation company, announces that, in partnership with its collaborator leadXpro (LXP), key milestones have been achieved in their protein structure driven GPR68 drug discovery project. As a result, Cumulus has licensed the small molecule compounds and associated IP created during this collaboration and...
Talus Bioscience, a drug discovery company founded by a world-class team of scientific leaders in proteomics, biochemistry, and machine learning, announced $11.2M in new venture funding. The Seed+ round was led by Two Bear Capital, with participation from WRF Capital, NFX, YC Continuity Fund, Funders Club VC, and BoxOne...
Agilisium, a premier digital innovations partner for Life Sciences companies, announced that it has been chosen as a leader by the Everest Group in their Life Sciences Digital Services for Mid-Market Enterprises PEAK Matrix® Assessment report, 2024. The assessment study involved the evaluation of the vision, capability (strategy, scope...
Paige, a leader in next-generation AI technology, announced a strategic shift to further advance the role and impact of AI in cancer care. This initiative includes leveraging its AI technology to bring Artificial General Intelligence (AGI) to pathology and oncology, as well as transitioning its diagnostic AI applications from...
Scispot®, known for its Gen AI-powered lab technology, has launched a new AI integration package tailored for life science labs. This solution enables R&D and testing labs to incorporate advanced AI capabilities into their existing workflows without the need for costly system upgrades.
Leveraging its proprietary technologies—Scibot™, Labsheets®, and GLUE—Scispot's AI...
Veridix AI, part of Emmes Group, a dedicated technology CRO (contract research organization) powered by artificial intelligence, announced the launch of new protocol digitization capabilities. This advanced tool lays the foundation for speeding up the clinical trial design process by up to 30%.
The new concept, created within Veridix AI's...
4G Clinical, a global leader in randomization and trial supply management (RTSM) and supply forecasting optimization software for the life sciences industry, announced the appointment of Ronan Brown, PhD as their new Chief Operating Officer. Brown's addition will further strengthen the executive team in support of 4G's commitment to...
Quantiphi, an award-winning AI-first digital engineering company announced it has acquired a strategic minority interest in leading stem cell-based biotech innovator Transcell, marking a milestone in AI-supported drug discovery in the life sciences industry.
Quantiphi Global Head of Healthcare and Life Sciences Barinder Marhok said the strategic investment aligns with Quantiphi's decade-plus commitment to solve what...
Persist AI and Nivagen have announced a collaboration to co-develop a next-generation manufacturing process for long-acting injectable (LAI) drugs, using Persist's AI-based formulation technology and Nivagen's manufacturing capabilities. The collaboration aims to simplify and accelerate the development and approval of LAI drugs, which can provide sustained and controlled release of...
Scispot, a leading provider of modern lab tech stack solutions, is thrilled to announce its new purpose-built Pathology LIMS alternative, engineered to deliver lightning-fast performance from sample intake to processing, instrument data analysis, and reporting. This new GenAI-powered solution is designed to help pathology labs process samples 5-10x faster,...
